在标准肝素、硫酸皮肤素和聚硫酸戊聚糖存在的情况下，抗凝血酶III和肝素辅因子II对凝血酶诱导的血小板聚集和5-羟色胺释放的抑制作用。 - Suppr | 超能文献

Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.

作者信息

Sié P, Fernandez F, Caranobe C, Gabaig A M, Boneu B

出版信息

Thromb Res. 1984 Jul 15;35(2):231-6. doi: 10.1016/0049-3848(84)90217-2.

DOI:10.1016/0049-3848(84)90217-2

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.在标准肝素、硫酸皮肤素和聚硫酸戊聚糖存在的情况下，抗凝血酶III和肝素辅因子II对凝血酶诱导的血小板聚集和5-羟色胺释放的抑制作用。

Thromb Res. 1984 Jul 15;35(2):231-6. doi: 10.1016/0049-3848(84)90217-2.

2

Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.抗凝血酶III和肝素辅因子II在肝素及各种硫酸化多糖体外抗凝作用中的各自作用。

Br J Haematol. 1986 Dec;64(4):707-14. doi: 10.1111/j.1365-2141.1986.tb02232.x.

3

Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.硫酸化多糖抑制凝血酶活性生成的机制。

Ann N Y Acad Sci. 1986;485:41-55. doi: 10.1111/j.1749-6632.1986.tb34566.x.

4

Synergistic inhibition by antithrombin III and heparin-like compounds of thrombin-induced platelet aggregation [proceedings].抗凝血酶III与类肝素化合物对凝血酶诱导的血小板聚集的协同抑制作用[会议论文集]

Biochem Soc Trans. 1980 Feb;8(1):85-6. doi: 10.1042/bst0080085.

5

Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).鉴定肝素辅因子II为戊聚糖多硫酸盐（SP54）抗凝血酶活性的主要血浆辅因子。

Thromb Res. 1984 Oct 15;36(2):187-94. doi: 10.1016/0049-3848(84)90340-2.

6

Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.硫酸化木聚糖在[125I] - 凝血酶与人血浆抗凝血酶III或肝素辅因子II相互作用过程中的作用。

Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):73-7. doi: 10.1007/BF03192291.

7

Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.纤维蛋白可调节肝素对人血浆中凝血酶抑制的催化作用，但对硫酸皮肤素的催化作用无此调节作用。

J Lab Clin Med. 1991 May;117(5):359-64.

8

Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.肝素辅因子II及其他内源性因子在肝素和硫酸皮肤素抗血栓形成及抗凝作用的介导过程中所起的作用

Semin Thromb Hemost. 1985 Apr;11(2):133-7. doi: 10.1055/s-2007-1004370.

9

Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.过度硫酸化软骨素和硫酸皮肤素对抗凝血酶III或肝素辅因子II灭活凝血酶和因子Xa的影响。

Biochem J. 1988 Sep 1;254(2):547-51. doi: 10.1042/bj2540547.

10

The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.凝血酶抑制对于肝素、硫酸皮肤素、低分子量肝素和聚硫酸戊聚糖抗凝活性表达的重要性。

Br J Haematol. 1985 Aug;60(4):695-704. doi: 10.1111/j.1365-2141.1985.tb07474.x.

引用本文的文献

1

The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers.硫酸皮肤素MF701在健康人类志愿者体内的药代动力学。

Br J Clin Pharmacol. 1991 Sep;32(3):361-6. doi: 10.1111/j.1365-2125.1991.tb03912.x.